Publications found:
73,128
Sort by:
IVF Services Market - 2024-2031
US$ 3,400.00
IVF Services Marketis is growing with a CAGR of 16.30% during the forecast period 2026-2035. The IVF Services Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where season...
September 2024
38 pages
Hair Loss Medication Market - 2024-2031
US$ 3,400.00
Hair Loss Medication Marketis is growing with a CAGR of 5.62% during the forecast period 2026-2035. The Hair Loss Medication Market emerges as a key focus in DataM Intelligence latest in-depth analysi...
September 2024
46 pages
Keloid Treatment Market - 2024-2031
US$ 3,400.00
Keloid Treatment Marketis is growing with a CAGR of 9.90% during the forecast period 2026-2035. The Keloid Treatment Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where...
September 2024
42 pages
Osteosynthesis Devices Market Size, Share & Trends Analysis Report By Type (Internal, External), By Material (Degradable, Non Degradable), By Fracture (Facial bones, Skull), By Region, And Segment Forecasts, 2024 - 2030
US$ 5,950.00
The osteosynthesis devices market size is expected to reach a value of USD 9.9 billion by 2024, according to a new ... for leading the drive for constant innovation in the osteosynthesis devices market. Some of the key players in this industry include DePuy Synthes, ...
September 2024
150 pages
Healthcare Cloud Computing Market Size, Share & Trends Analysis Report By Type (Clinical Information Systems, Non-clinical Information Systems), By Deployment, By Pricing Model, By Service Model, By End-use, By Region, And Segment Forecasts, 2024 - 2030
US$ 5,950.00
The global healthcare cloud computing market size is expected to reach USD 27.8 billion by 2026, according to a new report ... from payers as well as providers Some key players of this healthcare cloud computing market include Athenahealth, Cerner Corporation, CareCloud Corporation, Carestream Corporation, Epic ...
September 2024
100 pages
Pet Dental Health Market Size, Share & Trends Analysis Report By Animal Type (Dogs, Cats), By Type (Products, Services), By Indication (Gum Diseases, Endodontic Disease), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
US$ 5,950.00
This report can be delivered to the clients within 2 Business Days Personalized Retail Nutrition And Wellness Market Growth & Trends The global personalized retail nutrition and wellness market size...
September 2024
150 pages
Healthcare Satellite Connectivity Market Size, Share & Trends Analysis Report By Component (Medical Devices, System & Software), By Application (Telemedicine), By Connectivity, By End Use, By Region, And Segment Forecasts, 2024 - 2030
US$ 5,950.00
The global healthcare satellite connectivity market is expected to reach USD 10.1 billion by 2025 according to a ... in satellite connectivity are also undertaking projects in order to enhance healthcare provisions in underserved regions. For instance, Satellite Applications Catapult, a satellite technology ...
September 2024
100 pages
Global Human Microchipping Market Size Study, by Application (Medical Identification and Monitoring, Personal Identification and Access Control, Financial Transactions, and Others), by Type (Implantable Microchips and Non-Implantable Microchips), by Technology (RFID, NFC, and Others), by End User (Healthcare, Financial Services, Retail and Logistics, Government and Law Enforcement, and Others) and Regional Forecasts 2022-2032
US$ 3,000.00
The Global Human Microchipping Market, valued at approximately USD 1.70 billion in 2023, is projected to grow with a healthy growth rate of more than 7% over the forecast period 2024-2032. Human micro...
September 2024
200 pages
Global Pharmaceutical Intermediates Market Size Study, By Intermediate Type (Bulk Intermediate, Chemical Intermediate), By Application (Anti-Infective Drugs, Analgesics, Antidiabetic Drugs, Cardiovascular Drugs, Antimicrobial Drugs, Anti-inflammatory Drugs, Others), By End User (Biopharmaceutical Companies, CMO, CRO, Others) and Regional Forecasts 2022-2032
US$ 3,000.00
The global pharmaceutical intermediates market is valued at approximately USD 40.40 billion in 2023 and is expected to grow at a healthy compound annual growth rate (CAGR) of 8.10% during the forecast...
September 2024
200 pages
Western Blotting Market Size, Share & Trends Analysis Report, By Type (Instruments), By Application (Biomedical & Biochemical Research, Disease Diagnostics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
US$ 5,950.00
This report can be delivered to the clients within 3 Business Days Western Blotting Market Growth & Trends The global western blotting market size is expected to reach USD 1.48 billion by 2030, regi...
September 2024
100 pages
Thalassemia Market Size, Share & Trends Analysis Report By Treatment (Iron Chelating Drugs, Erythroid Maturation Agents, Stem Cell Therapy), By Type (Alpha Thalassemia, Beta Thalassemia), By Region, And Segment Forecasts, 2024 - 2030
US$ 5,950.00
The global thalassemia market size is expected to be valued at USD 3.53 billion by 2022, as per a new report by Grand ... gene therapy Regionally, among the seven major markets, EU5 held the dominant share in terms of revenue in 2016, followed by U.S. and Japan U.S. is expected ...
September 2024
80 pages
Europe Nutrition And Supplements Market, By Product (Sports Nutrition, Fat Burners, Dietary Supplements, Functional Foods & Beverages), By Consumer Group (Infants, Children, Adults, Pregnant, Geriatric), By Formulation (Tablets, Capsules, Powders, Softgels, Liquid, Others), By End Use (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), By Country, Competition, Forecast & Opportunities, 2019-2029F
US$ 4,000.00
Europe Nutrition And Supplements Market was valued at USD 65.05 billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 6.33% through 2029. The pursuit of a h...
September 2024
133 pages
Biological Treatment Technologies Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Treatment (Composting, Vermicomposting, Black Soldier fly treatment, Anerobic Digestion, Fermentation), By Application (Residential, Commercial, Industrial), By Region and Competition, 2019-2029F
US$ 4,500.00
Global Biological Treatment Technologies Market was valued at USD 2.47 Billion in 2023 and is anticipated to witness a steady growth in the forecast period with a CAGR of 4.25% through 2029. Biologica...
September 2024
185 pages
Europe Collagen Supplement Market By Form (Powdered, Capsules and Gummies, Drinks and Shots), By Source (Animal-based Collagen Supplements, Marine-based Collagen Supplements), By Distribution Channel (Pharmacies and Drug Stores, Online, and Hypermarkets and Supermarkets), By Country, Competition, Forecast, and Opportunities, 2019-2029F
US$ 4,000.00
Europe Collagen Supplement Market was valued at USD 652.35 Million in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 4.68% through 2029. Collagen supplements ha...
September 2024
133 pages
Europe Dietary Supplement Market By Product Type (Vitamin, Combination Dietary Supplement, Herbal Supplement, Fish Oil & Omega Fatty Acid, Protein and Other), By Form (Tablets, Capsules, Liquid, Powder, and Soft Gels), By Application (Energy& Weight Management, General Health, Bone & Joint Health, Immunity and Others), By Distribution Channel (Pharmacies and Drug Stores, Online, and Hypermarkets and Supermarkets), By Country, Competition, Forecast and Opportunities, 2019-2029F
US$ 4,000.00
Europe Dietary Supplement Market was valued at USD 35.18 billion in 2023 and is expected to reach USD 51.71 billion by 2029 with a CAGR of 6.59% during the forecast period. This expansion is propelled...
September 2024
133 pages
Europe Insect Processing Systems Market By Type (Liquid Handling System, Drying System, Others), By Application (Feed, Food, Others), By Country, Competition, Forecast, Opportunities, 2019-2029F
US$ 4,000.00
Europe Insect Processing Systems Market was valued at USD 451.39 Million in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 4.29% through 2029. The Europe Insect...
September 2024
131 pages
Europe Pre-Workout Supplements Market By Type (Powder, Capsule/ Tablet, Drinks, Other), By Distribution Channel (Online, Offline), By Country, Competition, Forecast, and Opportunities, 2019-2029F
US$ 4,000.00
Europe Pre-Workout Supplements Market was valued at USD 1.52 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 4.79% through 2029. Pre-workout supplemen...
September 2024
133 pages
France Human Insulin Market By Indication (Type I Diabetes, Type II Diabetes), By Brand (Lantus, Humulin R, Novolin R, Humulin N, Exubera, Afrezza, Novolin N), By Route of Administration (Subcutaneous, Nasal, Intravenous, Transdermal, Oral and Others), By Type (Basal, Bolus, Pre-mixed, Biosimilar, Traditional), By Onset Time (Rapid Acting, Short-Acting, Intermediate Acting, Long Acting, Ultra-long Acting, Pre-Mixed, Inhaled), By Products (Insulin Pens, Insulin Pumps, Infusion System, Injection), By Region, Competition Forecast & Opportunities, 2019-2029F
US$ 3,500.00
France Human Insulin Market was valued at USD 1.58 billion in 2023 and is anticipated to grow in the forecast period with a CAGR of 7.98% through 2029. The Human Insulin Market in France has been expe...
September 2024
80 pages
France Precision Medicine Market By Products & Services (Precision Medicine Platforms, Precision Medicine Tools, Precision Medicine Services), By Technology (Big Data Analytics, Artificial Intelligence, Bioinformatics, Whole Genome Sequencing, Companion Diagnostics, Next Generation Sequencing (NGS), Others), By Application (Oncology, Cardiology, Respiratory, Neurology, Immunology, Others), By End User (Pharmaceutical and Biotechnology Companies, Healthcare IT, Diagnostic Companies, Clinical Research Organization, Research Institutes), By Region, Competition Forecast & Opportunities, 2019-2029F
US$ 3,500.00
France Precision Medicine Market was valued at USD 3.71 billion in 2023 and is anticipated to grow in the forecast period with a CAGR of 10.33% through 2029. The precision medicine market in France ha...
September 2024
80 pages
India Oncology NGS Market By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted & Gene Panel Sequencing), By Application (Diagnostics and Screening, Companion Diagnostics, Other Diagnostics), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
India Oncology NGS Market was valued at USD 22.01 million in 2024 and is anticipated to reach USD 33.45 Million by 2030, with a CAGR of 7.89% during forecast period. The India Oncology NGS (Next-Gener...
September 2024
87 pages
Japan Alzheimer’s Therapeutics Market, By Product (Cholinesterase inhibitors, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs), By End User (Hospital Pharmacy, Retail Pharmacy, E-commerce), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Alzheimer’s Therapeutics Market was valued at USD 80.25 million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.25% through 2030. The Japan Alzheimer...
September 2024
82 pages
Japan Biosimilars Market, By Product (Monoclonal Antibodies, Recombinant Hormones, Immunomodulators, Anti-inflammatory Agents, Other), By Application (Blood Disorders, Growth Hormonal Deficiency, Chronic and Autoimmune Disorders, Oncology, Other), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Biosimilars Market was valued at USD 502.09 Million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.12% through 2030. The Japan biosimilars market is...
September 2024
82 pages
Japan Blood Plasma Market, By Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others), By Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Others), By End User (Hospitals, Clinics, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Blood Plasma Market was valued at USD 1.40 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.25% through 2030. Vitamin supplements are desig...
September 2024
82 pages
Japan Burn Care Market, By Burn Type (Thermal Burn, Electrical Burn, Chemical Burn, Radiation Burn, Friction Burn, Others), By Product Type (Advanced Burn Care, Biologics, Traditional Burn Care, Other), By Route of Administration (Oral, Parenteral, Others), By End User (Hospitals, Specialty Clinics, Others), By Distribution Channel (Online, Offline), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Burn Care Market was valued at USD 90.57 million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.05% through 2030. The Japan Burn Care Market is e...
September 2024
82 pages
Japan Cancer Supportive Care Market, By Therapeutics Class (G-CSFs (Granulocyte-colony Stimulating Factors), ESAs (Erythropoiesis Stimulating Agents), Anti-emetics, Bisphosphonates, Opioids, NSAIDs, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Cancer Supportive Care Market was valued at USD 365.25 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 2.25% through 2030. Vitamin supplements a...
September 2024
82 pages
Japan Diabetic Retinopathy Therapeutic Market By Type (Proliferative DR, Non-proliferative DR), By Management (Anti-VEGF Therapy, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Diabetic Retinopathy Therapeutic Market was valued at USD 373.25 Million in 2024 and is expected to reach USD 531.94 Million by 2030 with a CAGR of 6.04% during the forecast period. The Japan di...
September 2024
80 pages
Japan Infectious Disease Drugs Market, By Disease (HIV, Influenza, Hepatitis, Tuberculosis, Malaria, Other), By Treatment (Antibacterial, Antiviral, Antiparasitic, Other), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Infectious Disease Drugs Market was valued at USD 3.52 billion in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 4.25% through 2030. The Japan Infectious...
September 2024
82 pages
Japan Influenza Medications Market By Type (Antiviral Drugs, Antihistamines, Vaccines, Others), By Route of Administration (Oral, Inhaled), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Influenza Medications Market was valued at USD 84.61 Million in 2024 and is expected to reach USD 123.61 Million by 2030 with a CAGR of 6.48% during the forecast period. The Japan Influenza Medi...
September 2024
80 pages
Japan Interferons Market By Product Type (Interferon Alpha, Interferon Beta, And Interferon-Gamma), By Application (Hepatitis B, Hepatitis C, Melanoma, Leukemia, Multiple Sclerosis, and Renal Cell Carcinoma), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Interferons Market was valued at USD 64.75 Million in 2024 and is expected to reach USD 95.99 Million by 2030 with a CAGR of 6.74% during the forecast period. The Japan interferons market is bei...
September 2024
80 pages
Japan Precision Medicine Market, By Application (Diagnostics, Therapeutics), By End User (Home Care, Hospitals, Clinical Laboratories, Others), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Precision Medicine Market was valued at USD 450.12 million in 2024 and is anticipated to project robust growth in the forecast period with a CAGR of 10.50% through 2030. The Japan Precision Medi...
September 2024
82 pages
Japan Prostate Cancer Drugs Market, By Drug Class (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Sales, Others), By End User (Clinics, Hospital, Others), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Prostate Cancer Drugs Market was valued at USD 350.12 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.28% through 2030. The Japan Prostate...
September 2024
82 pages
Japan Psoriasis Drugs Market, By Therapeutic Class (Tumor Necrosis Factor Inhibitor, Interleukin Inhibitors, Others), By Treatment (Topicals, Systemic, Biologics), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Psoriasis Drugs Market was valued at USD 450.25 billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.85% through 2030. The Japan Psoriasis Drug...
September 2024
82 pages
Japan Pulmonary Arterial Hypertension Drugs Market, By Drug Class (Endothelin Receptor Antagonists (ERAs), Phosphodiesterase-5 (PDE-5) Inhibitors, Soluble Guanylate Cyclase (sGC) Stimulators, Prostacyclin Analogues, Calcium Channel Blockers, Others), By Route of Administration (Oral, Inhalation, Intravenous, Subcutaneous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Pulmonary Arterial Hypertension Drugs Market was valued at USD 230.11 million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.38% through 2030. The Ja...
September 2024
82 pages
Japan Rabies Vaccine Market, By Product Type (Chick embryo cells rabies vaccine, Vero cell rabies vaccine, Human diploid cell vaccine, Others), By Application (Human, Animal), By End User (Hospitals, Veterinary clinics, Others), By Region, Competition, Forecast and Opportunities, 2020-2030F
US$ 3,500.00
Japan Rabies Vaccine Market was valued at USD 35.25 million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 4.68% through 2030. The Japan rabies vaccine marke...
September 2024
82 pages
Japan Renal Cancer Drugs Market, By Type (Renal Cell Carcinoma (RCC), Papillary Renal Cell Carcinoma, Chromophobe Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Transitional Cell Carcinoma, Wilms Tumor (Nephroblastoma), Renal Sarcoma, Angiomyolipoma, Oncocytoma, Others), By Drug Class (Monoclonal Antibodies, mTOR Inhibitors, Immune Checkpoint Inhibitor, Combined Therapies, Interleukin-2, Alpha-Interferon, Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Renal Cancer Drugs Market was valued at USD 305.12 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.25% through 2030. The Japanese renal ca...
September 2024
82 pages
Japan Respiratory Drugs Market, By Type (Asthma, Chronic Obstructive Pulmonary Disease, Idiopathic Pulmonary Fibrosis, Cystic Fibrosis), By Application (Hospitals, Ambulatory Care, Homecare, Pharmacies), By Age Group (Pediatric, Adult), By Distribution Channel (Prescription, Over-the-Counter), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Respiratory Drugs Market was valued at USD 404.95 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.85% through 2030. The Japan Respiratory...
September 2024
82 pages
Japan Rheumatoid Arthritis Drugs Market, By Molecule Type (Pharmaceuticals, Biopharmaceuticals), By Drug Class (Non-steroidal Anti-inflammatory Drugs (NSAIDs), Corticosteroids, Analgesics, Other) By Distribution Channel (Prescription, Over-the-counter (OTC)), By Region, Competition, Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Rheumatoid Arthritis Drugs Market was valued at USD 585.22 Million in 2024 and is anticipated to project steady growth in the forecast period with a CAGR of 5.58% through 2030. Vitamin supplemen...
September 2024
82 pages
Japan Sarcoma Drugs Market, By Treatment Type (Chemotherapy, Targeted Therapy, Others), By Distribution Channel (Hospital pharmacy, Retail pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2020-2030F
US$ 3,500.00
Japan Sarcoma Drugs Market was valued at USD 32.25 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.85% through 2030. The Japan Sarcoma Drugs Mar...
September 2024
82 pages
